Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00467 |
| Species: | Homo sapiens |
| Position : | chr1:156092084-156093294 |
| Year: | 2021 |
| Title: | Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cardiomyopathy |
| PMID: | 33478249 |
| MONDO: | MONDO:0004994 |
| Tissue: | left cardiac ventricle |
| Tissue Ontology ID: | UBERON:0002084 |
| Cell Source: | human iPSC-derived cardiomyocytes |
| Cell Type: | ventricular cardiomyocyte |
| Cell Ontology ID: | CL:0000746 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | Promoter Capture Hi-C; H3K27ac ChIP-seq; ATAC-seq; H3K4me3 ChIP-seq; CTCF ChIP-seq; cardiac TF ChIP-seq; gnomAD variant filtering; GTEx eQTL analysis |
| Low Throughput Method: | Luciferase reporter assay in human iPSC-derived cardiomyocytes |
| Target gene : | LMNA |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|